Properties of calcium phosphate ceramics in relation to their in vivo behavior

Journal of Trauma - Injury, Infection and Critical Care

Volumn 48, Issue 1, 2000, Pages 179-186

  Blokhuis, Taco J ^a   Termaat, Marco F ^a   Den Boer, Frank C ^a   Patka, Peter ^a   Bakker, Fred C ^a   Haarman, Henk J Th M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE;

BIOCOMPATIBILITY; BONE CONDUCTION; BONE DEVELOPMENT; BONE PROSTHESIS; CERAMICS; CONFERENCE PAPER; POROSITY; PRIORITY JOURNAL;

EID: 0033984088     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-200001000-00037     Document Type: Conference Paper

References (100)

1. Guthrie D. A History of Medicine. London: Thomas Nelson and Sons, Ltd; 1945.
2. Meek'ren J. Heel-en geneeskonstige aanmerkingen. Amsterdam: Casparus Commelijn; 1668.
3. Albee FH. Fundamentals in bone transplantation. Experiences in three thousand bone graft operations. JAMA. 1923;81:1429-1432.
4. Sasso RC, Williams JI, Dimasi N, Meyer PR. Postoperative drains at the donor sites of iliac-crest bone grafts: a prospective, randomized study of morbidity at the donor site in patients who had a traumatic injury of the spine. J Bone Joint Surg Am. 1998;80:631-635.
5. Cockin J. Autologous bone grafting: complications at the donor site. J Bone Joint Surg Br. 1971;53:153-153.
6. Dreesman H. Ubber Knochenplombierung. Beitr Klin Chir. 1894;9:804.
7. de Groot K. Degradable ceramics. In: Williams DF, ed. Biocompatibility of Clinical Implant Materials. Boca Raton, Fla: CRC Press; 1981:199-222.
8. Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop. 1981;259-278.
9. Driskell TD, O'Hara MJ, Sheets HDJ, Greene GW Jr, Natiella JR, Armitage J. Development of ceramic and ceramic composite devices for maxillofacial applications. J Biomed Mater Res. 1972;6:345-361.
10. Lane JM, Bostrom MP. Bone grafting and new composite biosynthetic graft materials. Instr Course Led. 1998; 47:525-534.
11. Klawitter JJ, Hulbert SF. Application of porous ceramics for the attachment of load bearing orthopedic applications. J Biomed Mater Res Symp. 1971;2:161.
12. Daculsi G, Passuti N. Effect of the macroporosity for osseous substitution of calcium phosphate ceramics. Biomaterials. 1990;11:86-87.
13. Roy DM, Linnehan SK. Hydroxyapatite formed from coral skeletal carbonate by hydrothermal exchange. Nature. 1974;247:220-222.
14. Le Huec JC, Schaeverbeke T, Clement D, Faber J, Le Rebeller A. Influence of porosity on the mechanical resistance of hydroxyapatite ceramics under compressive stress. Biomaterials. 1995;16:113-118.
15. Lemons JE. Bioceramics. Is there a difference? Clin Orthop. 1990;153-158.
16. Osborn JF, Newesely H. The material science of calcium phosphate ceramics. Biomaterials. 1980;1:108-111.
17. Niwa S, Sawai K, Takahashi S, Tagai H, Ono M, Fukuda Y. Experimental studies of the implantation of hydroxyapatite in the medullary canal of rabbits. Paper presented at: First World Biomaterials Congress; April 4-10, 1980; Baden, Austria.
18. Jarcho M, Kay JF, Gumaer KI, Doremus RH, Drobeck HP. Tissue, cellular and subcellular events at a bone-ceramic hydroxylapatite interface. J Bioeng. 1977;1:79-92.
19. Lemons JE. Ceramics: past, present, and future. Bone. 1996;19:121S-128S.
20. Dennis JE, Haynesworth SE, Young RG, Caplan AI. Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant. 1992;1:23-32.
21. Encyclopedic Handbook of Biomaterials and Bioengineering. New York: Marcel Dekker, Inc; 1995.
22. Patka, P. Bone Replacement by Calcium Phosphate Ceramics. An Experimental Study, [thesis]. Amsterdam: Free University Press; 1984.
23. Hyakuna K, Yamamuro T, Kotoura Y, et al. Surface reactions of calcium phosphate ceramics to various solutions. J Biomed Mater Res. 1990;24:471-488.
24. Bagambisa FB, Joos U, Schilli W. Mechanisms and structure of the bond between bone and hydroxyapatite ceramics. J Biomed Mater Res. 1993;27:1047-1055.
25. American Society for Testing and Materials. Specification for Ceramic Hydroxyapatite far Surgical Implantation. Philadelphia: American Society for Testing and Materials; 1989:1185-1188.
26. Carvalho BA, Bajpai PK, Graves GA. Effect of resorbable calcium aluminate ceramics on regulation of calcium and phosphorus in rats. Biomedicine. 1976;25:130-133.
27. Driessen FCM. Formation and stability of calcium phosphate in relation to the phase composition of the mineral in calcified tissues. In: de Groot K, ed. Bioceramics of Calcium Phosphate. Boca Raton, Fla: CRC Press; 1982:1-33.
28. Williams DF, ed. Concise Encyclopedia of Medical and Dental Materials. Oxford, UK: Pergamon Press; 1991.
29. Hench L, Ethridge E. Biomaterials: An Interfacial Approach. San Diego: Academic Press; 1982.
30. Smith L. Cerosium. Arch Surg. 1963;87:653-655.
31. Hulbert SF, Morrison SJ, Klawitter JJ. Tissue reaction to three ceramics of porous and non-porous structures. J Biomed Mater Res. 1972;6:347-374.
32. Jarcho M, Bolen CH, Bobick J, Kay JP, Doremus RH. Hydroxyapatite synthesis and characterization in dense polycrystalline form. J Mater Sci. 1976;11:2027-2035.
33. De Aza PN, Guitian F, De Aza S. Bioeutectic: a new ceramic material for human bone replacement. Biomaterials. 1997;18:1285-1291.
34. Yamada KM, Olden K. Fibronectins: adhesive glycoproteins of cell surface and blood. Nature. 1978; 275:179-184.
35. Yamada KM. Immunological characterization of a major transformation-sensitive fibroblast cell surface glycoprotein. Localization, redistribution, and role in cell shape. J Cell Biol. 1978;78:520-541.
36. Bagambisa FB, Joos U. Preliminary studies on the phenomenological behaviour of osteoblasts cultured on hydroxyapatite ceramics. Biomaterials. 1990;11:50-56.
37. Yamada S, Heymann D, Bouler JM, Daculsi G. Osteoclastic resorption of calcium phosphate ceramics with different hydroxyapatite/beta-tricalcium phosphate ratios. Biomaterials. 1997;18:1037-1041.
38. Curtis ASG. Cell adhesion. Prog Biophys Mol Biol. 1973; 28:317-386.
39. Culp LA. Substrate-attached glycoproteins mediating adhesion of normal and virus-transformed mouse fibroblasts. J Cell Biol. 1974;63:71-83.
40. Hulbert SF, Cooke FW, Klawitter JJ, et al. Attachment of prostheses to the musculoskeletal system by tissue ingrowth and mechanical interlocking. J Biomed Mater Res. 1973;7:1-23.
41. Graves GA, Hentrich RL, Stein HG, Bajpai PK. Resorbable ceramics implants. J Biomed Mater Res Symp. 1971;2:91-115.
42. Duscheyne P, Lemons JE, eds. Bioceramics: Material Characteristics versus In Vivo Behavior. New York: New York Academy of Sciences; 1988.
43. Yamada S, Heymann D, Bouler JM, Daculsi G. Osteoclastic resorption of biphasic calcium phosphate ceramic in vitro. J Biomed Mater Res. 1997;37:346-352.
44. van Blitterswijk CA, Grote JJ, Kuijpers W, Daems WT, de Groot K. Macropore tissue ingrowth: a quantitative and qualitative study on hydroxyapatite ceramic. Biomaterials. 1986;7:137-143.
45. Gross UM, Muller-Mai CM, Voigt C. The interface of calcium-phosphate and glass-ceramic in bone, a structural analysis. Biomaterials. 1990;11:83-85.
46. Frankenburg EP, Goldstein SA, Bauer TW, Harris SA, Poser, RD. Biomechanical and histological evaluation of a calcium phosphate cement. J Bone Joint Surg Am. 1998; 80:1112-1124.
47. Hayden JM, Mohan S, Baylink DJ. The insulin-like growth factor system and the coupling of formation to resorption. Bone. 1995;17:93S-98S.
48. Nakahara H, Goldberg VM, Caplan AI. Culture-expanded periosteal-derived cells exhibit osteochondrogenic potential in porous calcium phosphate ceramics in vivo. Clin Orthop. 1992;291-298.
49. Goujon E. Recherches experimentales sur les propriétés physiologiques de la moelle des os. Journal de l'Anatomie et de Physiologie Normales et Pathologiques de l'Homme et des Animaux 1869;6:399.
50. Goshima J, Goldberg VM, Caplan AI. The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. Clin Orthop. 1991;274-283.
51. Gray JC, Elves MW. Donor cells' contribution to osteogenesis in experimental cancellous bone grafts. Clin Orthop. 1982;261-271.
52. Axhausen W. The osteogenic phases of regeneration of bone. J Bone Joint Surg. 1956;38:593-597.
53. Burwell RG. Studies in the transplantation of bone. 8. Treated composite homograft-autografts of cancellous bone: an analysis of inductive mechanisms in bone transplantation. J Bone Joint Surg Br. 1966;48:532-566.
54. Danis A. Après une greffe de tissu squelettiqueostéogène, c'est à partir des cellules transplantées que se constitué l'os denouvelle formation. Bull Soc Int Chir. 1960;6:647-652.
55. Danis A. Fracture callus originates directly or indirectly in the bone marrow. Acta Orthop Belg. 1973;39:696-709.
56. Rosin A, Freiberg H, Sajnek G. The fate of bone marrow, spleen and periosteum cultivated in vivo in the diffusion chamber with special reference to bone formation. Exp Cell Res. 1963;29:176-187.
57. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966;16:381-390.
58. Ashton BA, Allen TD, Hewlett CR, Eaglesom CC, Hattori A, Owen M. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthop. 1980;294-307.
59. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991; 9:641-650.
60. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem. 1994;56:283-294.
61. Lane JM, Yasko A, Tomin E, Bostrom M, Rosen V, Wozney J. Orthopedic application of BMP-2 in fracture healing. Paper presented at: First International Conference on Bone Morphogenetic Proteins; June 8, 1994; Baltimore, Md.
62. Nade S, Armstrong L, McCartney E, Baggaley B. Osteogenesis after bone and bone marrow transplantation. The ability of ceramic materials to sustain osteogenesis from transplanted bone marrow cells: preliminary studies. Clin Orthop. 1983;255-263.
63. Goshima J, Goldberg VM, Caplan AI. The osteogenic potential of culture-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks. Clin Orthop. 1991;298-311.
64. Grundel RE, Chapman MW, Yee T, Moore DC. Autogeneic bone marrow and porous biphasic calcium phosphate ceramic for segmental bone defects in the canine ulna. Clin Orthop. 1991;244-258.
65. Ohgushi H, Goldberg VM, Caplan AI. Repair of bone defects with marrow cells and porous ceramic. Experiments in rats. Acta Orthop Scand. 1989;60:334-339.
66. Ohgushi H, Goldberg VM, Caplan AI. Heterotopic Osteogenesis in porous ceramics induced by marrow cells. J Orthop Res. 1989;7:568-578.
67. Bab I, Passi-Even L, Gazit D, et al. Osteogenesis in in vivo diffusion chamber cultures of human marrow cells. Bone Miner. 1988;4:373-386.
68. Makin M. Osteogenesis induced by vesical mucosal transplant in the guinea pig. J Bone Joint Surg Br. 1962; 44:165-167.
69. Urist MR. Bone: Formation by autoinduction. Science. 1965;150:893-899.
70. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science. 1988;242:1528-1534.
71. Hirano H, Urist MR. Bone-forming and bone-resorbing cell lines derived from bone marrow in tissue culture. Clin Orthop. 1981;234-248.
72. Chen P, Carrington JL, Hammonds RG, Reddi AH. Stimulation of chondrogenesis in limb bud mesoderm cells by recombinant human bone morphogenetic protein 2B (BMP-2B) and modulation by transforming growth factor beta 1 and beta 2. Exp Cell Res. 1991;195:509-515.
73. Urist MR, DeLange RJ, Finerman GA. Bone cell differentiation and growth factors. Science. 1983;220:680-686.
74. Yamaguchi A, Katagiri T, Ikeda T, et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol. 1991;113:681-687.
75. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev. 1992;32:160-167.
76. Nagamine T, Imamura T, Ishidou Y, et al. Immunohistochemical detection of activin A, follistatin, and activin receptors during fracture healing in the rat. J Orthop Res. 1998;16:314-321.
77. Ishidou Y, Kitajima I, Obama H, et al. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res. 1995; 10:1651-1659.
78. Einhorn TA, Trippel SB. Growth factor treatment of fractures. Instr Course Lect. 1997;46:483-486.
79. Bostrom MP, Lane JM, Berberian WS, et al. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res. 1995; 13:357-367.
80. Onishi T, Ishidou Y, Nagamine T, et al. Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone. 1998;22:605-612.
81. Riley EH, Lane JM, Urist MR, Lyons KM, Lieberman JR. Bone morphogenetic protein-2: biology and applications. Clin Orthop. 1996;39-46.
82. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop. 1994;302-312.
83. Kirker-Head CA, Gerhart TN, Armstrong R, Schelling SH, Carmel LA. Healing bone using recombinant human bone morphogenetic protein 2 and copolymer. Clin Orthop. 1998;205-217.
84. Kirker-Head CA, Gerhart TN, Schelling SH, Hennig GE, Wang E, Holtrop ME. Long-term healing of bone using recombinant human bone morphogenetic protein 2. Clin Orthop. 1995;222-230.
85. Gerhart TN, Kirker-Head CA, Kriz MJ, et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop. 1993; 317-326.
86. Cook SD, Wolfe MW, Salkeld SL, Rueger DC. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am. 1995;77:734-750.
87. Ripamonti U, van den Heever B, Sampath TK, Tucker MM, Rueger DC, Reddi AH. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1. bone morphogenetic protein-7). Growth Factors. 1996;13:273-289.
88. Cook SD, Rueger DC. Osteogenic protein-1: biology and applications. Clin Orthop. 1996;29-38.
89. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop. 1998;26-37.
90. Ripamonti U, Ma SS, Van DH, Reddi AH. Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates. Plast Reconstr Surg. 1992;90:382-393.
91. Urist MR, Lietze A, Dawson E. Beta-tricalcium phosphate delivery system for bone morphogenetic protein. Clin Orthop. 1984;277-280.
92. Ono I, Gunji H, Kaneko F, Saito T, Kuboki Y. Efficacy of hydroxyapatite ceramic as a carrier for recombinant human bone morphogenetic protein. J Craniofac Surg. 1995; 6:238-244.
93. Gao TJ, Lindholm TS, Kommonen B, et al. The use of a coral composite implant containing bone morphogenetic protein to repair a segmental tibial defect in sheep. Int Orthop. 1997;21:194-200.
94. Gao TJ, Lindholm TS, Kommonen B, et al. Enhanced healing of segmental tibial defects in sheep by a composite bone substitute composed of tricalcium phosphate cylinder, bone morphogenetic protein, and type IV collagen. J Biomed Mater Res. 1996;32:505-512.
95. Gao TJ, Lindholm TS, Marttinen A, Urist MR. Composites of bone morphogenetic protein (BMP) and type IV collagen, coral-derived coral hydroxyapatite, and tricalcium phosphate ceramics. Int Orthop. 1996;20:321-325.
96. Urist MR, Nilsson O, Rasmussen J, et al. Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs. Clin Orthop. 1987;295-304.
97. Hotz G, Herr G. Bone substitute with osteoinductive biomaterials: current and future clinical applications. Int J Oral Maxillofac Surg. 1994;23:413-417.
98. Katoh T, Sato K, Kawamura M, Iwata H, Miura T. Osteogenesis in sintered bone combined with bovine bone morphogenetic protein. Clin Orthop. 1993;266-275.
99. Blokhuis TJ, den Boer FC, Bramer JAM, et al. Stimulation of bone healing with recombinant human Osteogenic Protein-1 [abstract]. Bone. 1999;24:413-413.
100. Ripamonti U. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials. 1996;17:31-35.